Preclinical Pipeline Submission Form

Use this form to submit information about candidates in preclinical development.

The stages of development in the Pipeline align with the stages of development outlined in the TB Vaccine Development Pathway, which provides a proposed structured development path and suggested gating criteria and describes the different functions and capabilities typically required to advance a candidate TB vaccine to its next stage of development. The stage gates associated with phases of development are noted on this form.

By submitting information through this platform, you agree to have the information shared for public viewing and public use. Please do not submit confidential information or information that is not yet available for the public.

TB Vaccine Preclinical Candidate Submission Form

"*" indicates required fields

Please indicate if this is a new submission or an update for a vaccine candidate previously submitted*

Vaccine Candidate Information

Provide a brief description of the vaccine candidate (limit 400 characters), including vaccine platform, antigens expressed, adjuvant, and formulation, as relevant. Please do not summarize research and/or trial results in this section.
0 of 400 max characters
Type of Vaccine (required for new submissions)

Stage of Development (required for new submissions)
Please indicate the stage of development of this vaccine candidate. If a candidate is in more than one stage, indicate the latest stage of development. If the candidate is in human clinical trials, please complete the TB Vaccine Clinical Candidate Submission Form.

What is the primary target indication for this vaccine candidate? (required for new submissions)

Indicate any additional indication(s) for this vaccine candidate (check all that apply)
Please indicate the target population(s) for the vaccine candidate (check all that apply) (required for new submissions)
What is the target route of administration for this vaccine candidate?

Preclinical Candidate Information

Is research currently being conducted on this vaccine candidate?
In which animal model(s) has this vaccine candidate been tested? (Check all that apply)
Are the results published?
If the results of testing in animal model(s) are published, please upload the publication(s) here.
Drop files here or
Accepted file types: pdf, Max. file size: 300 MB, Max. files: 5.
    What is the predicted/hypothesized target immunological response this vaccine candidate is intended to generate?
    What immunological response has been experimentally demonstrated for this vaccine candidate? (Check all that apply)
    What is the intended preferential immune tissue localization of this vaccine candidate?
    What immune tissue localization has been experimentally demonstrated?
    Is this vaccine candidate intended to elicit trained immunity?

    Publications

    Please provide links or PDFs of publications of data validating immune responses, tissue localization, trained immunity, clinical research findings or other research data and findings about this candidate.
    You do not need to upload articles if weblinks are already provided above.
    Drop files here or
    Accepted file types: pdf, Max. file size: 10 MB, Max. files: 5.

      Other Information (Optional)

      If you have other information you would like to share about this candidate, please enter it here.

      Submitter Information

      Submitter Name*
      Submitter Email*
      MM slash DD slash YYYY
      Authorization*
      This field is hidden when viewing the form
      Newsletters
      Consent*

      Please confirm that all information is correct before submitting.